Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non-erosive reflux disease - efficacy of Esoxx, a hyaluronic acid-chondroitin sulphate based bioadhesive formulation.

V SavarinoF PaceCarmelo Scarpignatonull null

Published in: Alimentary pharmacology & therapeutics (2017)

The synergistic effect of Essox with PPI treatment suggests that mucosal protection added to acid suppression could improve symptoms and HRQL in NERD patients.

Keyphrases

clinical trial
hyaluronic acid
end stage renal disease
ejection fraction
newly diagnosed
open label
chronic kidney disease
study protocol
drug delivery
randomized controlled trial
double blind
patient reported outcomes
patient reported